Navigation Links
Senesco Technologies Enters Into Agreement For Up To $1.0 Million In Financing
Date:7/10/2009

ep to help advance its research in multiple myeloma with the goal of initiating a Phase I clinical trial.

"We are pleased to have raised this additional capital," commented Joel Brooks, Chief Financial Officer. "This funding allows us to remain focused on our goal of filing an Investigational New Drug Application and initiating a Phase I clinical trial for SNS-01."

Important Information

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The shares of common stock have been sold pursuant to an exemption from state and federal securities laws.

In connection with the private placement, the Company will prepare a proxy statement for the Company's stockholders to be filed with the Securities and Exchange Commission (the "SEC"). The proxy statement will contain information about the Company, the private placement and related matters. STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT CAREFULLY WHEN IT IS AVAILABLE, AS IT WILL CONTAIN IMPORTANT INFORMATION THAT STOCKHOLDERS SHOULD CONSIDER BEFORE MAKING A DECISION ABOUT APPROVING AN AMENDMENT TO THE COMPANY'S CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES.

In addition to receiving the proxy statement from the Company by mail, shareholders will be able to obtain the proxy statement, as well as other filings containing information about the Company, without charge, from the SEC's website (http://www.sec.gov) or, without charge, from the Company's website at www.senesco.com or by directing such req
'/>"/>

SOURCE Senesco Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ArborGen and Senesco Announce Wood Quality Results
2. Senesco Technologies, Inc. Announces the Appointment of Dr. Harlan W. Waksal, M.D. as Chairman of the Board of Directors and the Addition of Mr. Warren J. Isabelle, CFA to its Board of Directors
3. Senesco Presents Pre-Clinical Multiple Myeloma Data at the 12th Annual Meeting of the American Society of Gene Therapy
4. Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results
5. Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results
6. Senesco and Harris Moran Mutually Agree to Terminate Development and License Agreement Due to Restructuring
7. Senesco Appoints Harlan W. Waksal, M.D., to Board of Directors
8. Senescos Preclinical Multiple Myeloma Data to be Presented at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
9. Senesco Technologies Announces Successful Completion of First Milestone Related to Agreement with Bayer CropScience
10. Senesco Technologies Closes Remaining $3.0 Million of Previously Announced Financing
11. Senesco Signs a Supply Agreement for Polyplus-transfections Delivery System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 2015  StemProtein LLC, a leading manufacturer of ... Stemedica Cell Technologies Inc., announced today that it ... of StemProtein. Silberg will help advance the Company,s ... Cell Factors (SCFs), a significant consumer opportunity. ... and biopharmaceutical industries with substantial executive level experience ...
(Date:9/3/2015)... ... 2015 , ... Michigan-based technology startup Halo Wearables ... The device, called the Halo H1, is a wearable that monitors the user’s ... track trending interstitial fluid levels in the body, in addition to sodium-potassium ratios ...
(Date:9/2/2015)... 2, 2015 Research and Markets ... of Jain PharmaBiotech,s new report "Nanobiotechnology ... offering. An increasing use ... industries is anticipated. Nanotechnology will be applied ... from formulations for optimal delivery to diagnostic ...
(Date:9/2/2015)... 02, 2015 Research ... addition of Jain PharmaBiotech,s new report "Biochips ... to their offering. This report is ... and applications. The report starts with a description ... markets. Technologies include array comparative genomic hybridization (CGH), ...
Breaking Biology Technology:StemProtein Names Thomas H. Silberg As CEO, To Focus On Stem Cell Secreted Proteins Addresing A Variety Of Health And Beauty Related Needs 2StemProtein Names Thomas H. Silberg As CEO, To Focus On Stem Cell Secreted Proteins Addresing A Variety Of Health And Beauty Related Needs 3Technology Startup Halo Wearables to Unveil Non-Invasive Hydration Monitoring Device Early 2016 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3Global Biochips and Microarrays Technologies, Markets and Companies Report 2015 with Market Size in 2014 and Projected Value for the Years 2019 and 2024 2
... Biosciences, a privately held company leading the development of ... David J. Mazzo, Ph.D., President and Chief Executive Officer, ... at the Conrad Hotel in Tokyo, Japan. Dr. ... October 6, 2009. The Conference brings together premier biotechnology ...
... ... in the United States to determine the best way to protect their facilities both physically ... ... the FBI, will be offering a series of workshops around the country in the next ...
... The Matan Companies has teamed up with Federal Capital ... of the National Cancer Institute,s 330,000 square foot Advanced ... Frederick, Maryland. The state-of-the art 200 million dollar ... is slated for delivery in mid 2011. As ...
Cached Biology Technology:Regado Biosciences To Present at the 2009 Japan Biopharma Partnering Conference on October 6, 2009 2Matan Companies Teams with Federal Capital Partners to Finance the National Cancer Institute at Riverside Research Park in Frederick, Maryland 2Matan Companies Teams with Federal Capital Partners to Finance the National Cancer Institute at Riverside Research Park in Frederick, Maryland 3Matan Companies Teams with Federal Capital Partners to Finance the National Cancer Institute at Riverside Research Park in Frederick, Maryland 4
(Date:8/12/2015)... CORAL SPRINGS, Florida , August 12, 2015 /PRNewswire/ ... globally, the pace of mobile payment innovation and advanced ... continues to replace the way consumers rely on using ... forges ahead with reinventing the future for payment services ... Inc. (NASDAQ: NXTD ), :  Google, Inc. (NASDAQ: ...
(Date:8/12/2015)... Calif. , Aug. 12, 2015  Synaptics ... of human interface solutions, today announced that four ... announced Match-in-Sensor solution, have officially been named FIDO ... As part of the certification, Synaptics, Natural ID™ ... 1.0 Universal Authentication Framework (UAF) standard and are ...
(Date:8/10/2015)... BOSTON and TELTOW, Germany ... SensoMotoric Instruments (SMI), a world leader in Eye ... the completion of its OEM Eye Tracking Platform for ... Eye Tracking Platform contains reference designs for seamless integration ... kiosk systems, virtual reality HMDs and augmented reality smart ...
Breaking Biology News(10 mins):Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3
... will not become pregnant, and they cannot be helped by ... Gothenburg, Sweden, have identified a molecule called Cdk1 that has ... this could lead to an increased rate of successful IVF. ... struggle to become pregnant. In vitro fertilization (IVF) can help ...
... the University of California, Davis, have invented a superthin ... "The material itself (say, semiconductor wafers) would break ... of biomedical engineering. He and his fellow researchers have ... thick layer between two surfaces. Pan,s nanoglue, which conducts ...
... In a brief paper in the journal Bioinformatics ... Web-based program called Spliceman for predicting whether genetic mutations ... potentially leading to disease. "Spliceman takes a set ... likely these single nucleotide variants alter splicing phenotypes," write ...
Cached Biology News:Discovery of a molecule that initiates maturation of mammalian eggs can lead to more IVF pregnancies 2Will a genetic mutation cause trouble? Ask Spliceman 2
... Dish uses include large-scale colony-counting and plaque-lifting, ... Flexys TM automated colony picking and ... new product number, created to easily match ... yet, please order under the old Sigma-Aldrich ...
BD BioCoat Collagen IV 150 mm Culture Dishes...
Polymerase (RNA) II (DNA directed) polypeptide L...
Chicken Anti-Human DNA-directed RNA Polymerase II 7.6 Kd Polypeptide (POLR2L Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: ELISA, Western Blot...
Biology Products: